| || |
|Page 1 of 1 || Previous | Next |
| | SCOTT'S WEB LOG
JUNE 9, 2011 [Article, Endogenous] Teplizumab and DPT-1: "Not Dead Yet"?
Hopefully, Phil Southerland will pardon me for borrowing the title to his new BOOK (as far as I know, he cannot copyright a mere 3 words, although they can be trademarked, but that process takes a number of years of using the term consistently as a brand name before the U.S. Patent and Trademark Office will even consider it), but I felt like it made a compelling headline for today's post. and it's big-pharma partner GlaxoSmithKline, also facilitated by the JDRF.